Revolutionary new CGM system eliminates routine fingerpricks* for people with diabetes and is nearly one-third slimmer than previous generation
NZMS Diabetes is excited to announce the powerful and revolutionary Dexcom G6 Continuous Glucose Monitoring System (CGM) will be available in New Zealand for people with diabetes ages 2 years and up beginning in late April 2020.
“The Dexcom G6 represents the future of diabetes management. Not only does the product eliminate the need for fingerpricks, but it provides real time glucose data that empowers people with diabetes to better control their condition and live healthier lives,” said Paul Flynn, general manager for Americas and Asia Pacific at Dexcom.
New with Dexcom G6:
Dexcom G6 carries forward important features of current Dexcom CGM systems:
More details, including pricing options and exact availability dates, will be released by NZMS Diabetes in the coming weeks.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. ǂG6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every six hours. Taking a higher dose may affect the G6 readings. †To view a list of compatible devices, visit www.dexcom.com/compatibility
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
We are always happy to help, send us a message or enquiry